Interim Director for COVID-19 Response
Jonathan Pearce joined the Medical Research Council (MRC) in 2008. Prior to this Jonathan undertook academic research at Cambridge, Oxford and Toronto, followed by roles in life sciences venture capital and strategic consulting.
Jonathan is Director of Strategy and Planning and was formally Interim Director for COVID-19 Response. In his time at MRC he has had responsibility for Infections and Immunity, including leading the MRC’s Zika rapid response, chairing the £85 million UK Research and Innovation (UKRI) antimicrobial resistance (AMR) initiative and the UK AMR Funders Forum, led the council’s £60 million precision medicine initiative, and established the council’s translational research funding scheme, the DPFS.
Last updated: 31 March 2022